Dexamethason 21-tert-butylacetate is a bioactive compound. References: Terpos E, Katodritou E, Symeonidis A, Zagouri F, Gerofotis A, Christopoulou G, Gavriatopoulou M, Christoulas D, Ntanasis-Stathopoulos I, Kourakli A, Konstantinidou P, Kastritis E, Dimopoulos MA. Effect of induction therapy with lenalidomide, doxorubicin, and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma. Int J Cancer. 2019 Jan 16. doi: 10.1002/ijc.32125. [Epub ahead of print] PubMed PMID: 30650184.

纯度：≥98%

CAS：24668-75-5